HomeMeet the
Doctor
Privacy
PracticesServices
ProvidedTelehealth
GuidePatient
Portal
Office
Location
Contact USFAQ
Doctor
Privacy
PracticesServices
ProvidedTelehealth
GuidePatient
Portal
Office
Location
Contact USFAQ
In order to minimize the risk of contracting COVID-19 we are:
*Maintaining social distancing, immunization, sanitization and ventilation protocols as recommended by the CDC
*Limiting in-person visits based on medical necessity for in-person evaluation.
*Maintaining suite doors locked at all times
*Granting access to people who have an appointment and have completed a COVID questionnaire.
If you have an in-person appointment at our office, please complete the questionnaires sent to you with your appointment reminder and notify our staff via text at (916) 536-6030 upon arrival.
Note:
If you are attending the office with a friend or family member, please have each person fill out a COVID questionnaire as well. They can complete them here.
Federal law (Ryan Haight Act) prohibits prescribing of any controlled medications, such as stimulant medications used to treat ADHD, and many anti-anxiety and sleep medications, classified as benzodiazepines, and benzodiazepine-receptor agonists, such as Klonopin, Xanax, Ativan, Ambien, and Lunesta among others without an in person evaluation.
Since we are still limiting the in-person evaluations, Dr. Bonilla is renewing these kinds of medications for patients she has prescribed them to in the past, and making sure they are seen in-person at least once per year.
And weighing very carefully the decision to start these types of medications to any patients.
If you are seeking to establish care for the first time, and you think you would benefit from one of these medications, we encourage you to contact your insurance to get a list of providers who are offering in person visits to new patients.